Viewing Study NCT03912402


Ignite Creation Date: 2025-12-25 @ 3:56 AM
Ignite Modification Date: 2026-02-25 @ 11:04 PM
Study NCT ID: NCT03912402
Status: UNKNOWN
Last Update Posted: 2019-05-09
First Post: 2019-04-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA)
Sponsor: Biocad
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module